The Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute of Emory University accelerates discoveries that drive cancer diagnosis, detection, drug delivery and therapeutic approaches.
The Discovery and Developmental Therapeutics Research Program facilitates cancer drug discovery based on molecular targets, biomedical technology and clinical trials for therapeutic development.
Program members collaborate on developing the next generation of anti-cancer innovations, transitioning these advancements from the lab to clinical practice. The program encompasses basic scientists identifying new anti-cancer targets, translational researchers refining these discoveries for clinical use and physicians applying promising new cancer therapies and techniques to patient care.
Collaboration is central to the program's success in drug development. An important priority is supporting activities, resources and opportunities that promote collaboration and meet the multi-disciplinary research interests of its members.
The goal of the Discovery and Developmental Therapeutics Research Program is to direct leading-edge science and technologies into improved therapeutic and diagnostic approaches to reduce the cancer burden among patients within the state of Georgia and beyond.
The Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute has developed innovative cancer precision therapies aimed at reducing Georgia's cancer burden.
Tumor Treating Fields therapy can safely be used along with standard systemic therapies to extend survival without reducing quality of life.
